Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

10-14 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change
26/08/26	€0.5940	-1.00%
25/08/26	€0.6000	-1.15%
24/08/26	€0.6070	0.00%
21/08/26	€0.6070	-1.30%
20/08/26	€0.6150	+2.50%

Delayed Quote Deutsche Boerse AG

More quotes

Annual profits - Rate of surprise

Company calendar

Market Closed - Deutsche Boerse AG 10:01:30 26/08/2026 +04			5-day change	1st Jan Change
0.5940 ^EUR	-1.00%		-1.00%	-

07-24	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
07-09	Theraclion Announces Board Changes	CI

Market Cap	47.15M 54.94M 44.26M 40.42M 76.29M 5.24B 76.66M 524M 203M 2.64B 206M 202M 8.76B	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	55.01M 64.09M 51.63M 47.15M 88.99M 6.11B 89.42M 611M 237M 3.08B 241M 235M 10.21B	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	39.01%	Yield 2024 *	-	Yield 2025	-

07-24	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
07-09	Theraclion Announces Board Changes	CI
07-09	Theraclion Appoints New Chairman	MT
06-19	Claude Lenoir appointed interim chairman of Theraclion
06-19	Theraclion Chairman Steps Down; Interim Successor Named	MT
06-18	Theraclion Announces Board Changes	CI
06-08	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
06-05	Theraclion deploys first Sonovein system in China
06-05	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
06-04	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
06-04	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
06-01	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
05-11	Bouygues, Euronext, Vallourec... stocks to watch today in Paris

07-23	Theraclion Initiates Its Commercial Momentum in the First Half of 2026	BU
07-15	Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL	BU
07-09	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
06-18	Theraclion Announces the Evolution of Its Board of Directors	BU
06-08	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU

Theraclion Stock Deutsche Boerse AG

Stocks

941

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news : Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Price Extremes

Managers and Directors: Theraclion

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

07-23	THERACLION AMORCE SA DYNAMIQUE COMMERCIALE AU PREMIER SEMESTRE 2026
07-15	Theraclion: BILAN DU PREMIER SEMESTRE 2026 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LE CRÉDIT INDUSTRIEL ET COMMERCIAL
07-09	Vincent Gardès prend la présidence du conseil d'administration de Theraclion
07-09	THERACLION RENFORCE SA GOUVERNANCE EN NOMMANT VINCENT GARDÈS À LA PRÉSIDENCE DE SON CONSEIL D'ADMINISTRATION
06-19	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer

1 day	-1.00%
1 week	-1.00%
Current month	+9.59%
1 month	+7.22%
3 months	+10.00%

1 week	0.59	0.62
1 month	0.54	0.63
Current year	0.44	0.93
1 year	0.44	0.93
3 years	0.44	0.93
5 years	0.44	0.93
10 years	0.44	0.93

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	24/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Alexandra Rocher COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Mehdi El Glaoui BRD	Director/Board Member	-	22/06/2021
Cédric Bellanger BRD	Director/Board Member	-	28/01/2022
Lijuan Deng BRD	Director/Board Member	-	29/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	-1.00%	-1.00%	-	-	54.94M
THERMO FISHER SCIENTIFIC, INC.	+0.89%	+3.29%	+29.73%	+17.01%	234B
DANAHER CORPORATION	-0.28%	+1.83%	+4.42%	-15.72%	151B
INTUITIVE SURGICAL, INC.	-0.38%	-6.86%	-21.90%	+24.49%	131B
BOSTON SCIENTIFIC CORPORATION	-3.39%	-7.38%	-54.72%	-5.10%	69.81B
EDWARDS LIFESCIENCES CORPORATION	-0.10%	-1.63%	+11.70%	+19.18%	52.33B
SIEMENS HEALTHINEERS AG	-1.11%	-1.80%	-16.89%	-13.58%	50.91B
AGILENT TECHNOLOGIES, INC.	+0.20%	-0.21%	+31.09%	+29.58%	43.8B
WATERS CORPORATION	-0.07%	-0.40%	+39.86%	+51.51%	40.69B
RESMED, INC.	-0.38%	+2.19%	-17.35%	+46.41%	34B
Average	-0.42%	+0.04%	+0.66%	+17.09%	89.79B
Weighted average by Cap.	-0.14%	-0.04%	+3.83%	+12.05%

	2024	2025
Net sales	830K 967K 779K 712K 1.34M 92.26M 1.35M 9.22M 3.57M 46.54M 3.63M 3.55M 154M	652K 760K 612K 559K 1.05M 72.45M 1.06M 7.24M 2.81M 36.55M 2.85M 2.79M 121M
Net income	-5.76M -6.71M -5.4M -4.94M -9.31M -640M -9.36M -63.95M -24.78M -323M -25.18M -24.64M -1.07B	-5.69M -6.63M -5.34M -4.88M -9.21M -632M -9.25M -63.2M -24.49M -319M -24.89M -24.35M -1.06B
Net Debt	3.41M 3.97M 3.2M 2.92M 5.52M 379M 5.54M 37.89M 14.68M 191M 14.92M 14.6M 633M	7.85M 9.15M 7.37M 6.73M 12.7M 873M 12.76M 87.22M 33.8M 440M 34.35M 33.6M 1.46B